Clinical trial
Capecitabine or Observation After Surgery in Treating Patients With Biliary…
NCT00363584 · University Hospital Southampton NHS Foundation Trust, Other · Completed
Key facts
| NCT number | NCT00363584 |
|---|---|
| Title | Capecitabine or Observation After Surgery in Treating Patients With Biliary Tract Cancer |
| Official title | A Randomised Clinical Trial Evaluating Adjuvant Chemotherapy With Capecitabine Compared to Expectant Treatment Alone (Observation) Following Surgery for Biliary Tract Cancer |
| Lead sponsor | University Hospital Southampton NHS Foundation Trust, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Extrahepatic Bile Duct Cancer, Gallbladder Cancer, Liver Cancer |
| Intervention type | Drug, Other, Procedure |
| Interventions | capecitabine, clinical observation, adjuvant therapy |
| Enrollment | 360 |
| Start date | Mar 1, 2006 |
| Primary completion | Aug 1, 2013 |
| First posted | Aug 15, 2006 |
| Last update posted | Aug 26, 2013 |
| Countries | United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: